PL2176299T3 - Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003) - Google Patents
Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003)Info
- Publication number
- PL2176299T3 PL2176299T3 PL08751340T PL08751340T PL2176299T3 PL 2176299 T3 PL2176299 T3 PL 2176299T3 PL 08751340 T PL08751340 T PL 08751340T PL 08751340 T PL08751340 T PL 08751340T PL 2176299 T3 PL2176299 T3 PL 2176299T3
- Authority
- PL
- Poland
- Prior art keywords
- exopolysaccharide
- ncimb
- bifidobacterium infantis
- infantis
- bifidobacterium
- Prior art date
Links
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 title 1
- 229920002444 Exopolysaccharide Polymers 0.000 title 1
- 229940004120 bifidobacterium infantis Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Grain Derivatives (AREA)
- Saccharide Compounds (AREA)
- Dairy Products (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92424207P | 2007-05-04 | 2007-05-04 | |
| EP08751340.4A EP2176299B1 (en) | 2007-05-04 | 2008-05-02 | Exopolysaccharide from bifidobacterium infantis 35624 (ncimb 41003) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2176299T3 true PL2176299T3 (pl) | 2017-11-30 |
Family
ID=39563583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08751340T PL2176299T3 (pl) | 2007-05-04 | 2008-05-02 | Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003) |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8357794B2 (pl) |
| EP (1) | EP2176299B1 (pl) |
| JP (1) | JP2010526055A (pl) |
| KR (1) | KR20100020938A (pl) |
| CN (1) | CN101835806B (pl) |
| BR (1) | BRPI0811451A2 (pl) |
| CA (1) | CA2686314C (pl) |
| CO (1) | CO6251326A2 (pl) |
| ES (1) | ES2640351T3 (pl) |
| PL (1) | PL2176299T3 (pl) |
| RU (1) | RU2511044C2 (pl) |
| WO (1) | WO2008135959A1 (pl) |
| ZA (1) | ZA200907742B (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006012536A2 (en) | 2004-07-22 | 2006-02-02 | Ritter Andrew J | Methods and compositions for treating lactose intolerance |
| WO2010023178A1 (en) * | 2008-08-28 | 2010-03-04 | Chr. Hansen A/S | Pharmaceuticals comprising a bacterial polysaccharide |
| EP2400839B1 (en) | 2009-02-24 | 2016-09-07 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| JP5455203B2 (ja) * | 2009-08-03 | 2014-03-26 | 森下仁丹株式会社 | フィルム製剤およびその製造方法 |
| EP3202406A1 (en) | 2010-04-28 | 2017-08-09 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| KR101569043B1 (ko) | 2013-08-28 | 2015-11-13 | 한국식품연구원 | 바실러스 서브틸리스 j-92 및 이를 이용하여 세포외다당류를 대량 생산하는 방법 |
| US20180280453A1 (en) | 2015-08-27 | 2018-10-04 | Alimentary Health Limited | Use of bifidobacterium longum and an exopolysaccharide produced thereby |
| EP3341082B1 (en) | 2015-08-27 | 2020-12-16 | PrecisionBiotics Group Limited | Bifidobacterium longum |
| RU2662310C9 (ru) | 2015-12-04 | 2018-09-21 | Виктор Вениаминович Тец | Средство (варианты) и способы восстановления микрофлоры |
| ES2760076T3 (es) * | 2015-12-11 | 2020-05-13 | Prec Group Limited | Bifidobacterium longum para el tratamiento de obesidad y trastornos metabólicos asociados |
| IT201600122724A1 (it) * | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
| EP3589726A1 (en) | 2017-02-28 | 2020-01-08 | Alimentary Health Limited | Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection |
| JP7055814B2 (ja) * | 2017-02-28 | 2022-04-18 | プリシジョンバイオティクス・グループ・リミテッド | 呼吸器ウイルス感染症に対する免疫応答を有利に調節することができるビフィドバクテリウム・ロンガム |
| WO2018180728A1 (ja) * | 2017-03-30 | 2018-10-04 | 森永乳業株式会社 | 炎症制御遺伝子の発現促進用組成物 |
| CN106977617B (zh) * | 2017-04-12 | 2019-08-20 | 常州谙美生物科技有限公司 | 益生菌中具有抗紫外、修复敏感皮肤及抗衰老功能的多糖及其分离方法和应用 |
| MX2020007946A (es) * | 2018-01-29 | 2021-02-09 | Prec Group Limited | Un producto de combinacion para profilaxis y tratamiento de sindrome de intestino irritable. |
| DK3745870T3 (da) * | 2018-01-29 | 2023-02-20 | Prec Group Limited | Et kombinationsprodukt til profylakse og behandling af irritabel tarmsyndrom |
| WO2021180973A1 (en) | 2020-03-13 | 2021-09-16 | Precisionbiotics Group Limited | Bifidobacterium longum |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61257930A (ja) * | 1985-05-09 | 1986-11-15 | Morinaga Milk Ind Co Ltd | 感染防御剤 |
| CH679677A5 (pl) * | 1989-09-29 | 1992-03-31 | Om Lab Sa | |
| ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
-
2008
- 2008-05-02 WO PCT/IE2008/000054 patent/WO2008135959A1/en not_active Ceased
- 2008-05-02 CN CN2008800146985A patent/CN101835806B/zh not_active Expired - Fee Related
- 2008-05-02 ES ES08751340.4T patent/ES2640351T3/es active Active
- 2008-05-02 RU RU2009140353/10A patent/RU2511044C2/ru active
- 2008-05-02 PL PL08751340T patent/PL2176299T3/pl unknown
- 2008-05-02 BR BRPI0811451-0A2A patent/BRPI0811451A2/pt not_active Application Discontinuation
- 2008-05-02 CA CA2686314A patent/CA2686314C/en active Active
- 2008-05-02 ZA ZA200907742A patent/ZA200907742B/xx unknown
- 2008-05-02 JP JP2010504996A patent/JP2010526055A/ja not_active Withdrawn
- 2008-05-02 KR KR1020097023111A patent/KR20100020938A/ko not_active Withdrawn
- 2008-05-02 EP EP08751340.4A patent/EP2176299B1/en active Active
- 2008-05-02 US US12/451,250 patent/US8357794B2/en not_active Expired - Fee Related
-
2009
- 2009-11-09 CO CO09126669A patent/CO6251326A2/es not_active Application Discontinuation
-
2013
- 2013-01-10 US US13/738,426 patent/US20130261071A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US8357794B2 (en) | 2013-01-22 |
| JP2010526055A (ja) | 2010-07-29 |
| AU2008246968A1 (en) | 2008-11-13 |
| EP2176299B1 (en) | 2017-07-05 |
| ZA200907742B (en) | 2010-07-28 |
| CA2686314C (en) | 2015-10-13 |
| BRPI0811451A2 (pt) | 2014-11-04 |
| US20110046084A1 (en) | 2011-02-24 |
| WO2008135959A1 (en) | 2008-11-13 |
| US20130261071A1 (en) | 2013-10-03 |
| CO6251326A2 (es) | 2011-02-21 |
| KR20100020938A (ko) | 2010-02-23 |
| RU2009140353A (ru) | 2011-06-10 |
| CN101835806A (zh) | 2010-09-15 |
| EP2176299A1 (en) | 2010-04-21 |
| RU2511044C2 (ru) | 2014-04-10 |
| CN101835806B (zh) | 2012-11-07 |
| CA2686314A1 (en) | 2008-11-13 |
| ES2640351T3 (es) | 2017-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2176299T3 (pl) | Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003) | |
| PL2134833T3 (pl) | Probiotyczny szczep Bifidobacterium | |
| GB2460781B (en) | Probiotic bifidobacterium strains | |
| PL2352389T3 (pl) | Bifidobacterium longum | |
| PL2034848T3 (pl) | Bakteria Streptococcus thermophilus | |
| GB0715936D0 (en) | Mutant bacterium | |
| PL380803A1 (pl) | Nowy szczep Bifidobacterium longum | |
| HUP0700337A2 (en) | Mutant bradyrhizobium bacterium | |
| GB0702034D0 (en) | Avt 1 | |
| PL380804A1 (pl) | Nowy szczep Lactobacillus rhamnosus | |
| GB0723669D0 (en) | T m 4 | |
| GB0714681D0 (en) | Note 020 | |
| GB0714691D0 (en) | Note 009 | |
| GB0714674D0 (en) | Note 013 | |
| GB0714675D0 (en) | Note 014 | |
| GB0714678D0 (en) | Note 017 | |
| GB0714679D0 (en) | Note 018 | |
| GB0714672D0 (en) | Note 011 | |
| GB0714682D0 (en) | Note 021 | |
| GB0714683D0 (en) | Note 001 | |
| GB0714685D0 (en) | note 003 | |
| GB0714686D0 (en) | Note 004 | |
| GB0714687D0 (en) | Note 005 | |
| GB0714688D0 (en) | Note 006 | |
| GB0714689D0 (en) | Note 007 |